Difference between revisions of "KRT7-AS"
Line 18: | Line 18: | ||
===Expression=== | ===Expression=== | ||
In the same samples, KRT7 mRNA levels are much higher than KRT7-AS levels. In MKN28 and KATOIII cells, KRT7 mRNA is 61 and 41 fold higher than KRT7-AS (P<0.01). | In the same samples, KRT7 mRNA levels are much higher than KRT7-AS levels. In MKN28 and KATOIII cells, KRT7 mRNA is 61 and 41 fold higher than KRT7-AS (P<0.01). | ||
+ | |||
+ | ===Function=== | ||
+ | KRT7-AS and KRT7 mRNA form a duplex RNA-RNA structure at their overlapping region, which can increase KRT7 mRNA Stability and protect KRT7 mRNA from degradation.<ref name="ref1"/> | ||
+ | The overexpressed KRT7-AS in gastric cancer cells leads to increased proliferation and migration.<ref name="ref1"/> | ||
+ | |||
===Disease=== | ===Disease=== |
Revision as of 09:07, 15 October 2017
Contents
Annotated Information
Approved Symbol
KRT7-AS (KRT7 antisense RNA 1)
Chromosome
12q13.13
RefSeq
NG_012296
Characteristics
KRT7-AS is localized to the nucleus and it shares a 213-nucleotide-long region with the seventh exon of KRT7.[1]
Expression
In the same samples, KRT7 mRNA levels are much higher than KRT7-AS levels. In MKN28 and KATOIII cells, KRT7 mRNA is 61 and 41 fold higher than KRT7-AS (P<0.01).
Function
KRT7-AS and KRT7 mRNA form a duplex RNA-RNA structure at their overlapping region, which can increase KRT7 mRNA Stability and protect KRT7 mRNA from degradation.[1] The overexpressed KRT7-AS in gastric cancer cells leads to increased proliferation and migration.[1]
Disease
gastric cancer
Labs working on this lncRNA
- Department of Gastroenterology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
- Division of Gastroenterology, Departments of Medicine and Oncology and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.